The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1

被引:220
作者
GoddenKent, D
Talbot, SJ
Boshoff, C
Chang, Y
Moore, P
Weiss, RA
Mittnacht, S
机构
[1] INST CANC RES, CHESTER BEATTY LABS, CTR MOL & CELL BIOL, LONDON SW3 6JB, ENGLAND
[2] INST CANC RES, CHESTER BEATTY LABS, CTR VIROL, LONDON SW3 6JB, ENGLAND
[3] COLUMBIA UNIV, SCH PUBL HLTH, DIV EPIDEMIOL, NEW YORK, NY USA
[4] COLUMBIA UNIV COLL PHYS & SURG, DEPT PATHOL, NEW YORK, NY 10032 USA
关键词
D O I
10.1128/JVI.71.6.4193-4198.1997
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Kaposi's sarcoma-associated herpesvirus (KSHV or human herpesvirus 8) is a novel gammaherpesvirus implicated in the cause of Kaposi's sarcoma and certain malignancies of lymphatic origin. One of the candidate genes possibly involved in promoting tumor development is an open reading frame (ORF),vith sequence similarity to human type D cyclin genes. This cyclin-like gene, when expressed in tissue culture cells, promotes phosphorylation and inactivation of the retinoblastoma tumor suppressor protein and thereby may result in deregulation of cell division control. We report here the biochemical characterization of this cyclin (KSHV-cyc) and the kinase activity that it elicits upon expression in tissue culture cells. We demonstrate that the kinase activity associated with KSHV-cyc is sensitive to the cdk inhibitor p27 (KIP) and due to activation of cdk6. However, in contrast to cdk6 activated by cellular type D cyclins, the cdk6 activated by KSHV-cyc is capable of phosphorylating not only the retinoblastoma protein but also histone H1. This finding implies that activation by KSHV-cyc alters the substrate preference of this cdk. This may have important physiological consequences in that the kinase activity triggered by this viral cyclin may abrogate cell cycle checkpoints in addition to those targeted by cellular cyclin D-cdk6 kinase.
引用
收藏
页码:4193 / 4198
页数:6
相关论文
共 59 条
  • [1] HERPES-LIKE SEQUENCES IN HIV-INFECTED AND UNINFECTED KAPOSIS-SARCOMA PATIENTS
    AMBROZIAK, JA
    BLACKBOURN, DJ
    HERNDIER, BG
    GLOGAU, RG
    GULLETT, JH
    MCDONALD, AR
    LENNETTE, ET
    LEVY, JA
    [J]. SCIENCE, 1995, 268 (5210) : 582 - 583
  • [2] ARVANITAKIS L, 1995, J IMMUNOL, V155, P1047
  • [3] CYCLIN D1 IS A NUCLEAR-PROTEIN REQUIRED FOR CELL-CYCLE PROGRESSION IN G(1)
    BALDIN, V
    LUKAS, J
    MARCOTE, MJ
    PAGANO, M
    DRAETTA, G
    [J]. GENES & DEVELOPMENT, 1993, 7 (05) : 812 - 821
  • [4] BATES S, 1994, ONCOGENE, V9, P71
  • [5] CYCLIN D1 AS A CELLULAR PROTOONCOGENE
    BATES, S
    PETERS, G
    [J]. SEMINARS IN CANCER BIOLOGY, 1995, 6 (02) : 73 - 82
  • [6] BERAL V, 1991, CANCER SURV, V10, P5
  • [7] CYCLIN D1 TRANSGENE IMPEDES LYMPHOCYTE MATURATION AND COLLABORATES IN LYMPHOMAGENESIS WITH THE MYC GENE
    BODRUG, SE
    WARNER, BJ
    BATH, ML
    LINDEMAN, GJ
    HARRIS, AW
    ADAMS, JM
    [J]. EMBO JOURNAL, 1994, 13 (09) : 2124 - 2130
  • [8] KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS INFECTS ENDOTHELIAL AND SPINDLE CELLS
    BOSHOFF, C
    SCHULZ, TF
    KENNEDY, MM
    GRAHAM, AK
    FISHER, C
    THOMAS, A
    MCGEE, JO
    WEISS, RA
    OLEARY, JJ
    [J]. NATURE MEDICINE, 1995, 1 (12) : 1274 - 1278
  • [9] BOSHOFF C, 1995, LANCET, V345, P1043
  • [10] BOSHOFF C, UNPUB